Treatment for Pancreatic Cancer
Moffitt Cancer Center offers the latest advances in treatment for pancreatic cancer. Moffitt experts have a unique level of experience treating rare and highly complex malignancies, including cancers affecting the pancreas.
The multispecialty team of physicians at our Gastrointestinal Oncology Program takes a collaborative approach to treatment that focuses on addressing pancreatic cancer from several angles to achieve a positive outcome and a higher quality of life for patients. As a pancreatic cancer patient at Moffitt, your treatment team may include:
- Surgeons
- Medical oncologists
- Radiation oncologists
- Endoscopic specialists
- Endocrinologists
- Radiologists
- Pathologists
- And other medical professionals
Treatment for pancreatic cancer can take several forms. A combination of surgery, chemotherapy and radiation therapy is often recommended to remove tumors or halt their growth. At Moffitt, our physicians are highly experienced in practicing progressive treatments, such as endoscopic ultrasound therapy, minimally invasive robotic procedures and immunotherapy. Under the same roof, supportive care from dietitians, pain intervention specialists, social workers, counselors and other professionals are available to help patients cope with the physical and emotional challenges that can accompany a cancer diagnosis.
Additionally, Moffitt spearheads many robust clinical trials for pancreatic cancer, allowing our patients have access to the latest breakthroughs in pancreatic cancer treatment before they are made widely available. We are the only Florida-based, National Cancer Center Institute-designated Comprehensive Cancer Center – a distinction that speaks directly to our commitment to finding new, promising treatments for the most complex and challenging cancers.Â
For additional information regarding treatment for pancreatic cancer at Moffitt Cancer Center, call 1-888-663-3488Â or fill out a new patient registration form. A referral is not necessary to visit Moffitt.
Pancreatic Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer